A Study of Venetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participants With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT01671904 · COMPLETED
Trial details
- NCT number
- NCT01671904
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-13
- Primary completion
- 2018-08-17
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.